Evaluation of Anti-Mullerian Hormone in Predicting In Vitro Fertilization Cycle Outcomes

Aim: This study was conducted to explore the effect of serum anti-Mullerian hormone (AMH) level on in vitro fertilization (IVF) cycle outcomes. Material and Methods: A total 142 patients included this study, were divided into three groups according their AMH levels as Group 1: 5-10 ng/ml (n=108), 2: 10-15 (n=20), 3: >15 (n=14). Demographic characteristics recorded. The duration infertility stimulation, number cycles, initial, final, doses gonadotropins, estradiol (E2) progesterone day trigger, oocyte pick up (OPU) embryo transfer (ET), oocytes retrieved, mature oocytes, quality embryo, also endometrial thickness OPU ET, distance embryo-fundus, pregnancy outcomes all Results: While IVF treatment indications similar between groups, body mass index (BMI) significantly higher 2 3 than 1 (p<0.001). gonadotropin 3, count (p=0.006, p=0.015, respectively) Conclusion: associated with BMI count, but not quality,